earnings
saveSummit Therapeutics Inc. earnings
community read0 votes
Anticipated earnings call for Summit Therapeutics Inc. ($SMMT).
view source ↗Data sources
Found something off?
related news · 8
- biospaceAstraZeneca employs $1.5B cost savings to reinvest back into growth
- endpoints#ESMO26: Akeso details ivonescimab's biliary cancer success, drawing Keytruda comparisons
- biospaceDisc’s redemption, China’s rise, Veradermics’ validation, ESMO’s headliners
- biopharma diveHype vs. reality: What pharma’s hottest R&D bets have actually proved
- biospaceMerck/Moderna, Summit/Akeso and ADCs to headline ESMO 2026
- endpointsSummit partners with AstraZeneca and Daiichi; Eccogene earns $50M milestone
- statSTAT+: HHS announces new efforts to speed up, expand clinical trials with AI
- statSTAT+: Three biotech updates, including accusations of theft and and a new lobbying leader
comments(0)
5-min edit window · permanent after that